Phase I and pharmacokinetic study of DACA (XR5000): a novel inhibitor of topoisomerase I and II
暂无分享,去创建一个
P. Beale | N. Bleehen | P. Vasey | C. Twelves | C. Hutchison | J. Bono | I. Judson | A. Rodríguez | I. Dennis | A. Flavin | J. Sludden | M. Macham | C. Gardner | A. Rodríguez